Business Description
NextGen Biomed Ltd
ISIN : IL0010839301
Description
NextGen Biomed Ltd is pharmaceutical company. It manufactures medical instruments. Its products include pain-free auto-injectors, lancet devices and personal use pain alleviators. It develops and markets medical equipments. Its product line include DPS-101, which is used for treatment for psoriasis. Its other product line include DPS-101 phase II/III is in clinical trial.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -3.3 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -101.4 | |||||
| 3-Year EPS without NRI Growth Rate | -26.7 | |||||
| 3-Year FCF Growth Rate | -17.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 51.14 | |||||
| 9-Day RSI | 43.82 | |||||
| 14-Day RSI | 42.59 | |||||
| 6-1 Month Momentum % | -0.89 | |||||
| 12-1 Month Momentum % | -62.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.19 | |||||
| Quick Ratio | 0.19 | |||||
| Cash Ratio | 0.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.5 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -195.56 | |||||
| ROA % | -152.25 | |||||
| ROIC % | -74.81 | |||||
| ROC (Joel Greenblatt) % | -69121.95 | |||||
| ROCE % | -176.05 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -0.44 | |||||
| EV-to-EBITDA | -0.44 | |||||
| EV-to-FCF | -1.45 | |||||
| Earnings Yield (Greenblatt) % | -228.71 | |||||
| FCF Yield % | -69.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
NextGen Biomed Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | |||
| EPS (TTM) (₪) | -3.4 | ||
| Beta | 0 | ||
| Volatility % | 32.95 | ||
| 14-Day RSI | 42.59 | ||
| 14-Day ATR (₪) | 0.09035 | ||
| 20-Day SMA (₪) | 0.9282 | ||
| 12-1 Month Momentum % | -62.26 | ||
| 52-Week Range (₪) | 0.801 - 2.849999 | ||
| Shares Outstanding (Mil) | 7.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
NextGen Biomed Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
NextGen Biomed Ltd Stock Events
| Event | Date | Price(₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
NextGen Biomed Ltd Frequently Asked Questions
What is NextGen Biomed Ltd(XTAE:NXGN)'s stock price today?
The current price of XTAE:NXGN is ₪0.88. The 52 week high of XTAE:NXGN is ₪2.85 and 52 week low is ₪0.80.
When is next earnings date of NextGen Biomed Ltd(XTAE:NXGN)?
The next earnings date of NextGen Biomed Ltd(XTAE:NXGN) is .
Does NextGen Biomed Ltd(XTAE:NXGN) pay dividends? If so, how much?
NextGen Biomed Ltd(XTAE:NXGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers